MDS Proteomics teams with Agilent Technologies

Toronto’s MDS Proteomics Inc and Agilent Technologies Inc, Palo Alto CA, have entered an agreement to develop new protein analysis technologies and applications to accelerate the speed of medicine development. MDS will work with Agilent’s Bio-Consumables and Services division, which possesses expertise in separation science and liquid chromotography for identifying and characterizing proteins. MDS will contribute its expertise in protein pathway biology, mass spectrometry analysis and high-performance super computing. The value of the collaboration was not disclosed....